Changes in Antigen Carbohydrate 125 in Patients Receiving Dapagliflozin following an Admission for Acute Heart Failure
Introduction: Antigen carbohydrate 125 (CA125) has emerged as a proxy of fluid overload and inflammation in acute heart failure (AHF). We aimed to evaluate the influence of dapagliflozin on CA125 levels within the first weeks after discharge and whether CA125 changes were related to 6-mon...
Saved in:
| Main Authors: | Gema Miñana, Rafael de la Espriella, Miguel Lorenzo-Hernández, Enrique Rodriguez-Borja, Anna Mollar, Patricia Palau, Agustin Fernández-Cisnal, Ernesto Valero, Arturo Carratalá, Enrique Santas, Vicent Bodi, Juan Sanchis, Antoni Bayés-Genís, Eduardo Nuñez, Julio Nuñez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2025-01-01
|
| Series: | Cardiorenal Medicine |
| Online Access: | https://karger.com/article/doi/10.1159/000543417 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The modulating effect of circulating carbohydrate antigen 125 on ST2 and long-term recurrent morbidity burden
by: Elena Revuelta-López, et al.
Published: (2025-01-01) -
The Role of Antigen Carbohydrate 125 in Modulating Soluble ST2: Prognostic-Related Effects in Acute Heart Failure
by: Arancha Martí-Martínez, et al.
Published: (2025-04-01) -
Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction
by: Enrique Santas, et al.
Published: (2020-06-01) -
Biomarkers to Improve Decision-making in Acute Heart Failure
by: Rafael de la Espriella, et al.
Published: (2023-10-01) -
Carbohydrate Antigen-125
by: Vijay U. Rao, MD, PhD, et al.
Published: (2025-07-01)